ArticleFrontiers in oncology2026
Case Report: Granular cell tumor of the axillary tail mimicking node-positive breast carcinoma - two cases with imaging-pathology correlation.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Granular cell tumor of the breast (GCTB) is a rare Schwann-cell-derived neoplasm whose multimodal imaging features overlap extensively with those of invasive carcinoma, frequently exposing patients to unnecessarily extensive surgery in the absence of preoperative tissue diagnosis. We report two institutional cases with detailed imaging-pathology correlation. In Case 1, a 53-year-old postmenopausal woman with a 2.5-cm left axillary tail mass displayed convergent malignant-pattern features across all three imaging modalities - a BI-RADS 5 spiculated mass with skin retraction on mammography, marked posterior acoustic shadowing on ultrasound, and heterogeneous enhancement with a type II (plateau) kinetic curve on contrast-enhanced MRI (a pattern associated with intermediate-to-high suspicion for malignancy) - together with an ipsilateral axillary lymph node demonstrating type III (washout) kinetics. The composite preoperative picture was clinically indistinguishable from cT2N1M0 invasive carcinoma. After the patient declined preoperative core needle biopsy (CNB), breast-conserving surgery and sentinel lymph node biopsy were performed; final pathology confirmed benign GCTB (S-100+, SOX10+, CD68+, Pan-CK-, GATA3-, ER/PR/AR-; 0 of 6 Fanburg-Smith criteria) with reactive nodal hyperplasia. In Case 2, a 38-year-old premenopausal woman with a 0.9-cm right breast nodule underwent ultrasound-guided vacuum-assisted biopsy (VAB) yielding benign GCTB; histology demonstrated tumor cells encircling peripheral nerve bundles within the lesion - direct morphological evidence supporting the established Schwann-cell origin of the tumor. Both patients remained disease-free at 12 and 36 months. These cases reinforce that preoperative CNB with a targeted immunohistochemistry panel - explicitly distinguishing GCTB from ectopic axillary breast carcinoma - should be strongly recommended for any suspicious axillary tail mass; Case 1, in which the patient declined CNB and proceeded directly to surgery, illustrates by counter-example the diagnostic uncertainty that results when this step is omitted. We present these cases in accordance with the CARE reporting guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.